Cargando…

Diagnostic utility of the neutrophil-platelet ratio as a novel marker of activity in patients with Ulcerative Colitis

BACKGROUND: Ulcerative colitis (UC) is a chronic disease characterized by periods of activity and remission. The platelet, one of the main activators of neutrophils, contains Interleukin 8 (IL-8), a potent neutrophil chemo-attractant and P-selectin that induces excretion of superoxide in the neutrop...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yamamoto-Furusho, Jesús K., Mendieta-Escalante, Erick A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2020
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7173773/ https://www.ncbi.nlm.nih.gov/pubmed/32315368 http://dx.doi.org/10.1371/journal.pone.0231988

Ejemplares similares

The role of platelet to lymphocyte ratio and neutrophil to lymphocyte ratio in ulcerative colitis
por: Jeong, Yujin, et al.
Publicado: (2021)

Evaluation of neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio as potential markers for ulcerative colitis: a retrospective study
por: Feng, Wan, et al.
Publicado: (2022)

Clinical Utility of the Neutrophil-to-Bilirubin Ratio in the Detection of Disease Activity in Ulcerative Colitis
por: Huang, Xijing, et al.
Publicado: (2023)

Platelet-to-lymphocyte Ratio and Neutrophil-to-lymphocyte Ratio Predict Mucosal Disease Severity in Ulcerative Colitis
por: Akpinar, Muhammet Yener, et al.
Publicado: (2018)

The Utility of the Neutrophil-Lymphocyte Ratio as an Early Diagnostic Marker in Neonatal Sepsis
por: Panda, Santosh K, et al.
Publicado: (2021)

Neutrophil-to-Platelet Ratio in Patients with Ulcerative Colitis Treated with Infliximab or Vedolizumab: A Retrospective, Single-Center Study in Poland
por: Warpechowski, Marcin, et al.
Publicado: (2023)

Neutrophil-to-Lymphocyte Ratio for Predicting Loss of Response to Infliximab in Ulcerative Colitis
por: Nishida, Yu, et al.
Publicado: (2017)

Histopathologic Parameters at Diagnosis as Early Predictors of Histologic Remission along the Course of Ulcerative Colitis
por: Yamamoto-Furusho, Jesús K., et al.
Publicado: (2020)

Synthesis of Interleukin-10 in Patients with Ulcerative Colitis and Helicobacter pylori Infection
por: Yamamoto-Furusho, Jesús K., et al.
Publicado: (2020)

Neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio as predictive markers in hepatoblastoma
por: Xie, Tan, et al.
Publicado: (2023)

Differential Expression of MUC12, MUC16, and MUC20 in Patients with Active and Remission Ulcerative Colitis
por: Yamamoto-Furusho, Jesús K., et al.
Publicado: (2015)

ABCC7/CFTR Expression Is Associated with the Clinical Course of Ulcerative Colitis Patients
por: Villeda-Ramírez, Marco A., et al.
Publicado: (2021)

Markers of inflammation and influence of nitric oxide on platelet activation in the course of ulcerative colitis
por: Gawrońska, Beata, et al.
Publicado: (2017)

Neutrophil/lymphocyte ratio and lymphocyte/monocyte ratio in ulcerative colitis as non-invasive biomarkers of disease activity and severity
por: Okba, Ashraf M., et al.
Publicado: (2019)

The Transient Receptor Potential Vanilloid 1 Is Associated with Active Inflammation in Ulcerative Colitis
por: Toledo-Mauriño, Joel Jesús, et al.
Publicado: (2018)

Diagnostic Value of Neutrophil-to-Lymphocyte Ratio and Platelet-to-Lymphocyte Ratio in Crohn's Disease
por: Feng, Jue-Rong, et al.
Publicado: (2017)

Novel prognostic biomarkers of pouchitis after ileal pouch-anal anastomosis for ulcerative colitis: Neutrophil-to-lymphocyte ratio
por: Nishida, Yu, et al.
Publicado: (2020)

The Role of the Neutrophil-to-Lymphocyte Ratio and Platelet-to-Lymphocyte Ratio as Markers of Disease Activity in Ankylosing Spondylitis
por: Zeb, Alam, et al.
Publicado: (2019)

Evaluation of diet pattern related to the symptoms of mexican patients with Ulcerative Colitis (UC): through the validity of a questionnaire
por: Bueno-Hernández, Nallely, et al.
Publicado: (2015)

Autoantibodies as diagnostic markers and potential drivers of inflammation in ulcerative colitis
por: Jodeleit, Henrika, et al.
Publicado: (2020)

Association between Novel Marker (Platelet-Lymphocyte Ratio, Neutrophil-Lymphocyte Ratio, and Delta Neutrophil Index) and Outcomes in Sudden Cardiac Arrest Patients
por: Han, Sang Il, et al.
Publicado: (2021)

Circulating Ghrelin Levels and Obestatin/Ghrelin Ratio as a Marker of Activity in Ulcerative Colitis
por: Jung, Ja Young, et al.
Publicado: (2015)

Pretreatment neutrophil-to-lymphocyte ratio predicts clinical relapse of ulcerative colitis after tacrolimus induction
por: Nishida, Yu, et al.
Publicado: (2019)

Neutrophil-to-lymphocyte ratio may predict clinical relapse in ulcerative colitis patients with mucosal healing
por: Kurimoto, Noriyuki, et al.
Publicado: (2023)

Neutrophil-lymphocyte ratio and platelet-lymphocyte ratio as novel risk markers for diabetic nephropathy in patients with type 2 diabetes
por: Jaaban, Marwa, et al.
Publicado: (2021)

The Neutrophil-to-Monocyte Ratio and Platelet-to-White Blood Cell Ratio Represent Novel Prognostic Markers in Patients with Pancreatic Cancer
por: Tang, Feng, et al.
Publicado: (2021)

Neutrophil-to-Lymphocyte Ratio and Platelet-to-Lymphocyte Ratio Predict Mortality in Patients with Diabetic Foot Ulcers Undergoing Amputations
por: Chen, Wenwen, et al.
Publicado: (2021)

Neutrophil-Dependent Oxidative Stress in Ulcerative Colitis
por: Naito, Yuji, et al.
Publicado: (2007)

Treatment of Ulcerative Colitis: Impact on Platelet Aggregation
por: Peric, Sasa, et al.
Publicado: (2023)

Application of the neutrophil to lymphocyte ratio in the diagnosis and activity determination of ulcerative colitis: A meta-analysis and systematic review
por: Ma, Lushun, et al.
Publicado: (2021)

The diagnostic and prognostic value of neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio on gastric cancer patients
por: Nguyen, Mai Ly Thi, et al.
Publicado: (2023)

Peroxisome Proliferator-Activated Receptors Family Is Involved in the Response to Treatment and Mild Clinical Course in Patients with Ulcerative Colitis
por: Yamamoto-Furusho, J. K., et al.
Publicado: (2014)

Neutrophil-to-Lymphocyte Ratio and Platelet-to-Lymphocyte Ratio: Novel Markers for Diagnosis and Prognosis in Patients with Idiopathic Sudden Sensorineural Hearing Loss
por: Seo, Young Joon, et al.
Publicado: (2014)

First Trimester Mean Platelet Volume, Neutrophil to Lymphocyte Ratio, and Platelet to Lymphocyte Ratio Values Are Useful Markers for Predicting Preeclampsia
por: Oğlak, Süleyman Cemil, et al.
Publicado: (2021)

Utility of pre-treatment neutrophil–lymphocyte ratio and platelet–lymphocyte ratio as prognostic factors in breast cancer
por: Koh, C-H, et al.
Publicado: (2015)

Predictive utility of neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio in intraductal papillary neoplasm of the bile duct
por: Luvira, Vor, et al.
Publicado: (2019)

Utility of neutrophil–lymphocyte ratio and platelet–lymphocyte ratio in predicting acute-on-chronic liver failure survival
por: Li, Dong, et al.
Publicado: (2023)

Diagnostic and prognostic role of neutrophil/lymphocyte ratio, platelet/lymphocyte ratio, and lymphocyte/monocyte ratio in patients with osteosarcoma
por: Yapar, Aliekber, et al.
Publicado: (2021)

A practical marker to determining acute severe ulcerative colitis: CRP/albumin ratio
por: Sayar, Suleyman, et al.
Publicado: (2019)

Diagnostic role of mean platelet volume and neutrophil to lymphocyte ratio in childhood brucellosis
por: Bozdemir, Şefika Elmas, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_dshriq990c1rae6ddt2blh9f16